Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 4:44 PM
Ignite Modification Date: 2025-12-24 @ 4:44 PM
NCT ID: NCT00827866
Eligibility Criteria: Inclusion Criteria: * Participants smokes cigarettes * Participants is a cancer survivor * Participant must be at least 18 years of age. * Childhood cancer survivors must be at least one year out active cancer treatment. * Participant understands consent procedures. * Participant speaks English. * Participant must have access to a telephone for participation Exclusion Criteria: * Inability to understand consent procedures * Participants with a known contraindication or sensitivity to nicotine replacement therapy may participate in this study; however they will not receive nicotine replacement therapy (NRT) as part of their smoking cessation program. * Since our participants are childhood cancer survivors and they can be medically fragile and we are interested in providing all eligible participants with NRT to enhance their ability to quit smoking, we added a cautionary conditions list to the recruitment screening form. Those with severe arrhythmias, myocardial infarction, unstable angina, cerebrovascular incident, blood vessel disease, phaeochromocytoma, diabetes, hyperthyroidism, abnormal kidney or liver function, or history of gastritis or peptic ulcers, or who smoke less than 5 cigarettes per day will not receive NRT. * Patients with questionable NRT eligibility will be discussed/reviewed on a case by case basis with the Staff Family Physician
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT00827866
Study Brief:
Protocol Section: NCT00827866